rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lars Boesgaard

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, PDS Biotechnology; Vice President, CFO, Roka BioScience; Vice President of Finance, Insulet.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
0
First trade
21 Jun 2007
Last trade
12 Jan 2026
Last filed
3 Mar 2026

Companies traded

Where they are an officer
PDSB PDS BiotechnologyOfficer · Biotechnology · last 12 Jan 20260 buys · 0 sells
Roka BioScienceOfficer · last 24 Mar 20170 buys · 0 sells
PODD InsuletOfficer · Medical Devices · last 26 Feb 20090 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
12 Jan 2026filed 3 Mar 2026PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—300,000 at $0.00filing
12 Jan 2026filed 3 Mar 2026PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—300,000 at $0.00filing
12 Jun 2025filed 25 Jul 2025PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
4 Dec 2023filed 4 Dec 2023PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
24 Mar 2017filed 28 Mar 2017Roka BioScienceoption or derivativeSEC FORM 4 Code A—54,000 at $0.00filing
10 Nov 2016filed 10 Nov 2016Roka BioScienceSEC FORM 4 Code C$25K3,572 at $7.00filing
10 Nov 2016filed 10 Nov 2016Roka BioScienceoption or derivativeSEC FORM 4 Code C—25 at $0.00filing
21 Sep 2016filed 23 Sep 2016Roka BioScienceoption or derivativeSEC FORM 4 Code P—25filing
21 Sep 2016filed 23 Sep 2016Roka BioScienceoption or derivativeSEC FORM 4 Code P—35,714filing
4 Jan 2016filed 5 Jan 2016Roka BioScienceoption or derivativeSEC FORM 4 Code A—43,000 at $0.00filing
6 Dec 2015filed 7 Dec 2015Roka BioScienceSEC FORM 4 Code F$183128 at $1.43filing
26 Feb 2009filed 2 Mar 2009PODD Insuletoption or derivative · Medical DevicesSEC FORM 4 Code A—15,000 at $0.00filing
12 Mar 2008filed 14 Mar 2008PODD Insuletoption or derivative · Medical DevicesSEC FORM 4 Code A—15,000 at $0.00filing
8 Nov 2007filed 30 Jan 2008PODD Insuletoption or derivative · Medical DevicesSEC FORM 4 Code A—37,000 at $0.00filing
21 Jun 2007filed 25 Jun 2007PODD Insuletoption or derivative · Medical DevicesSEC FORM 4 Code A—38,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John Andrew DawsonDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Deborah RamsdellDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Bruce WendelDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Flavia PeaseEVP & CFO · EVP & CFO at Insulet, filing Form 4 there in the last year
Jonathan Jay MazelskyDirector · Director at Insulet, filing Form 4 there in the last year